Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc (TMO) Covered Calls
As of September 25, 2026, TMO has 234 covered call opportunities in the coming three months. Return ranges from 1.4 to 53.6% until expiration. Annualized return ranges from 10.1 to 387.0%. The nearest expiration is October 2, 2026. Maximum potential profit is $36,200.
Read more
Running TMO covered calls helps you generate consistent income from Thermo Fisher Scientific Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Thermo Fisher Scientific Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TMO covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TMO stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TMO covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Thermo Fisher Scientific Inc covered call is worth writing.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Income-focused investors, long-term TMO holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TMO covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Thermo Fisher Scientific Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV percentile98.41% Elevated
- Market cap (M$)249,579
- 52 weeks high-1.17%
- 52 weeks low55.08%
- Analyst recommendationBuy
1.52 - Target price$662.16
-1.90% below the current stock price - Dividend—
- Payout ratio9.70%
- Earnings date2026-10-28
- P/E36.31
- Future P/E24.61
- EPS (ttm)18.59
- EPS growth next 5 years9.85%
As of September 25, 2026
| 2026-10-02 | 7 | 725.00 | 7.41 | 0.10 | 1.10 | 5010.00 | 7.42 | 387.02 | -0.01 | +0.05 | 12 | 1.00 |
| 2026-10-02 | 7 | 720.00 | 6.67 | 0.20 | 7.10 | 4520.00 | 6.70 | 349.16 | -0.03 | +0.17 | 46 | 6.90 |
| 2026-10-02 | 7 | 715.00 | 5.93 | 0.35 | 2.35 | 4035.00 | 5.98 | 311.70 | -0.05 | +0.10 | 0 | 2.00 |
| 2026-10-02 | 7 | 710.00 | 5.19 | 0.70 | 2.60 | 3570.00 | 5.29 | 275.78 | -0.10 | +0.12 | 64 | 1.90 |
| 2026-10-16 | 21 | 780.00 | 15.56 | 0.10 | 1.10 | 10510.00 | 15.57 | 270.63 | -0.01 | +0.03 | 4 | 1.00 |
| 2026-10-16 | 21 | 770.00 | 14.07 | 0.30 | 1.50 | 9530.00 | 14.12 | 245.39 | -0.04 | +0.04 | 15 | 1.20 |
| 2026-10-16 | 21 | 760.00 | 12.59 | 0.15 | 1.50 | 8515.00 | 12.61 | 219.26 | -0.02 | +0.05 | 12 | 1.35 |
| 2026-10-09 | 14 | 730.00 | 8.15 | 0.75 | 3.00 | 5575.00 | 8.26 | 215.33 | -0.11 | +0.10 | 130 | 2.25 |
| 2026-10-02 | 7 | 700.00 | 3.70 | 1.50 | 3.60 | 2650.00 | 3.93 | 204.71 | -0.22 | +0.18 | 42 | 2.10 |
| 2026-10-23 | 28 | 780.00 | 15.56 | 0.15 | 7.00 | 10515.00 | 15.58 | 203.07 | -0.02 | +0.11 | 1 | 6.85 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best TMO covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→